Riociguat，BAY 63-2521 CAS NO.625115-55-1

FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
Min.Order: 100 Gram
Payment Terms: L/C
Available Specifications:
≥98.0%(100-500)Gram1/Gram100USD≥98.0%(1000-5000)Gram1/Gram1000USD

Product Details

Keywords

625115-55-1
Riociguat，BAY 63-2521
Riociguat;N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester;Bay 63-2521;Carbamic acid, (4,6-diamino-2-(1-((2-fluorophenyl)m

Quick Details

ProName: Riociguat，BAY 63-2521
CasNo: 625115-55-1
Molecular Formula: C20H19FN8O2
Appearance: white crystalline solid
Application: Aromatic derivatives; Heterocyclic; Ar...
DeliveryTime: 2 months
PackAge: 100g,500g,1kg,25kg/drum
Port: shang hai
ProductionCapacity: 1000 Gram/Week
Purity: ≥98.0%
Storage: Dry seal
Transportation: shipping
LimitNum: 100 Gram

Superiority

We are specialized in custom synthesis, chemical/pharmaceutical/ pesticides outsourcing and contract research.

We are committed to provide excellence in researching, manufacturing and drug discovery process.

Our research team of scientists consists of western-trained Ph.D.s with experience and capabilities in drug R&D methodologies and medicinal chemistry.

Details

Riociguat (BAY 63-2521) is a stimulator of soluble guanylate cyclase (sGC).
IC50 value:
Target: sGC stimulator
Riociguat (BAY 63-2521; BAY 632521) is a novel drug that is currently in clinical development by Bayer. At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.

Riociguat，BAY 63-2521 CAS NO.625115-55-1

Keywords

Quick Details

Superiority

Details

Other products of this supplier